Erica Shenoy is an Infectious Disease physician affiliated with Political Research Associates. OpenAlex indexes 213 publications with 5,980 citations (h-index 35); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Telephone
617-726-3812Registry record last updated 20 Dec 2012.
Clinical trials
- A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
Sponsor: Massachusetts General Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Opioid Agonist100%Loperamide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2014–2016 per NIH RePORTER. The latest:
- Improving clinical, operational and economic outcomes related to MRSA
Massachusetts General Hospital
FY2016$137,160K01AI110524 - Improving clinical, operational and economic outcomes related to MRSA
Massachusetts General Hospital
FY2015$136,821K01AI110524 - Improving clinical, operational and economic outcomes related to MRSA
Massachusetts General Hospital
FY2014$136,698K01AI110524
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Automating surveillance for healthcare-associated infections: Rationale and current realities (Part I/III)
Antimicrobial Stewardship & Healthcare Epidemiology
2023 - Universal Masking in Health Care Settings: A Pandemic Strategy Whose Time Has Come and Gone, For Now
Annals of Internal Medicine
2023 - Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
Open Forum Infectious Diseases
2022 - Case 24-2022: A 31-Year-Old Man with Perianal and Penile Ulcers, Rectal Pain, and Rash
New England Journal of Medicine
2022 - Monkeypox transmission following exposure in healthcare facilities in nonendemic settings: Low risk but limited literature
Infection Control and Hospital Epidemiology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”